REQUEST A DEMO
Total
USD $0.00
Search more companies

Neobiotek S.A.S. (Ecuador)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Neobiotek S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Neobiotek S.A.S. is an enterprise based in Ecuador. Its main office is in Quito. It operates in the Research and Development in the Physical, Engineering, and Life Sciences industry. It was established on February 23, 2023. 9 (2024) employees currently work for Neobiotek S.A.S.. There was a net sales revenue increase of 214.99% reported in Neobiotek S.A.S.’s latest financial highlights for 2024. There was a total growth of 5.29% in Neobiotek S.A.S.’s total assets over the same period. In, 2024, the company’s net profit margin decreased by 9.26%.

Headquarters
Av. Republica del Salvador, N35-146
Quito; Pichincha;

Contact Details: Purchase the Neobiotek S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Neobiotek S.A.S. report to view the information.
Registered Capital:
Purchase the Neobiotek S.A.S. report to view the information.
Financial Auditors:
Purchase the Neobiotek S.A.S. report to view the information.
Incorporation Date:
February 23, 2023
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Neobiotek S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
214.99%
Total operating revenue
214.99%
Operating Profit/Loss (EBIT)
87.53%
EBITDA
93.01%
Net Profit/Loss for the Period
66.74%
Total Assets
5.29%
Total Equity
54.19%
Operating Profit Margin (ROS)
-9.95%
Net Profit Margin
-9.26%
Return on Equity (ROE)
2.65%
Debt/Equity
-56.12%
Quick Ratio
0.74%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?